Expression of Cancer-Testis Antigen (CTA) Genes in Intrahepatic Cholangiocarcinoma
- 1 October 2004
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 11 (10) , 934-940
- https://doi.org/10.1245/aso.2004.01.029
Abstract
Background:Cancer-testis antigens (CTA), such as MAGE, are selectively expressed in various types of human neoplasms but not in normal tissues other than testis. This characteristic feature of CTA...Keywords
This publication has 25 references indexed in Scilit:
- Expression of MAGE‐A3 in intrahepatic cholangiocarcinoma and its precursor lesionsPathology International, 2004
- Identification of HLA-A24-Restricted CTL Epitope from Cancer-Testis Antigen, NY-ESO-1, and Induction of a Specific Antitumor Immune ResponseClinical Cancer Research, 2004
- Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998Gut, 2001
- Monoclonal antibody 57B stains tumor tissues that express geneMAGE-A4International Journal of Cancer, 2000
- Expression of MAGE Genes in Human Colorectal CarcinomaAnnals of Surgery, 1996
- Human esophageal carcinomas frequently express the tumor‐rejection antigens of MAGE genesInternational Journal of Cancer, 1995
- The expression of tumor-rejection antigen “MAGE” genes in human gastric carcinomaGastroenterology, 1995
- A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma.The Journal of Experimental Medicine, 1995
- BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytesImmunity, 1995
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991